The BridgeTech program was awarded funding from MTPConnect to deliver thisunique training program in 2018 & 2019. The BridgeTech Program was awarded

further funding from MTPConnect through the Biomedical Translation Bridge Fund to deliver the program for a further 3 years.

Learn more at mtpconnect.org.au

THE

BRIDGETECHPROGRAM

Transferring skills on the commercialisation of medical technology research

PROGRAM OUTLINEThe BridgeTech Program is a national professional development program that trains researchers and entrepreneurs on how to effectively navigate the medtech commercialisation pathway.

Convened and administered by QUT, the BridgeTech Program involves a consortium of partners including medtech companies, universities and industry associations.

Launched in 2018, the program selects up to 100 participants annually from across Australia to take part in face-to-face and online training, presented through an interactive, self-paced platform.

For more information email: bridgetech.program@qut.edu.au

or visit: https://research.qut.edu.au/bridgetech/

The BridgeTech Program provides specific training on the scientific, legal, financial, clinical, regulatory and reimbursement disciplines that are essential to medtech commercialisation.

The program is accessible from anywhere around Australia and involves: > Online learning materials through an interactive digital platform > BridgeTech Industry Talks series, reaching most capital cities in Australia > The BridgeTech Symposium, held in May over 3 days

As part of the BridgeTech program, participants also have the opportunity to participate in the PitchTech Competition by submitting a 2-minute video pitch. The top 2 pitches will be awarded an industry-based internship and attendance at an international medtech conference.

> Strengthen your skills so you can confidently navigate the commercialisation pathway.> Grow your network by connecting with leaders in the Australian medtech ecosystem.> Join an alumni community of over 150+ medtech professionals.

FEESThis course is fully supported by industry and government; there is no course fee.

Applications to be submitted through the online form, accompanied by a two-page CV.

Applications close on 31 January 2020.

Application portal: research.qut.edu.au/bridgetech/

The BridgeTech Program is available to professionals in the medtech sector, including: entrepreneurs, researchers, scientists, legal practitioners (IP & patents), clinicians, venture capitalists, business development personnel, tech transfer personnel and staff from regulatory and government agencies.

A demonstrated background in medtech and interest in a commercialisation career is essential.

WHO TO APPLY

HOW TO APPLY

BENEFITS

2020

ACHIEVEMENTS & DEVELOPMENTSJust nine months after completing the program, participants reported major advances in their medtech commercialisation journey, including:

THE

BRIDGETECHPROGRAM

participants had initiated or completed a patent

participants had been involved in the development of a new startup

participants had begun discussions with incubators

participants had pitched to investors or industry representatives

34participants had

initiated or completed an R&D contract

5

participants had initiated or completed a licence

2

participants had secured funding from grants/venture capital/angel investors/crowd funding or other avenues

5participants had initiated or completed a pre-clinical or clinical trial

participants had launched a new product

4Figures from 2018 cohort, 9-month post program survey

8

24

of respondents said that they had grown their networks in the

medtech commercialisation

ecosystem

100% of respondents said

that their developments were impacted, in whole

or in part, by their participation in the

BridgeTech Program

82%